Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women
Zhaoming Wang(St. Jude Children's Research Hospital), Wu‐Chou Su(National Cheng Kung University Hospital), Yukihide Momozawa(RIKEN Center for Integrative Medical Sciences), I‐Shou Chang(National Health Research Institutes), Taiki Yamji, Jiang Chang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Jie Seow(National University Health System), Yataro Daigo(The University of Tokyo), Nilanjan Chatterjee(Johns Hopkins University), Chao A. Hsiung(National Health Research Institutes), Neil E. Caporaso(Unknown), Kouya Shiraishi, Zhihua Yin(China Medical University), Takashi Kohno(Gunma University), Chen Wu(Central China Normal University), Guangfu Jin(Nanjing Health and Health Commission), Juncheng Dai(Nanjing Medical University), Zhehai Wang(Shandong Tumor Hospital), Sensen Cheng(Shandong Tumor Hospital), Shengchao A. Li(Leidos (United States)), Peng Guan(Children's Hospital of Zhejiang University), Yasushi Yatabe(University Hospital Münster), Keitaro Matsuo(Aichi Cancer Center), Wei Hu(National Institutes of Health), Yun‐Chul Hong(National University College), Laurie Burdett(National Cancer Institute), Wen Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Tetsuya Mitsudomi(Kindai University), Maria Teresa Landi(National Institutes of Health), Zhibin Hu(Nanjing Medical University), Toyoaki Hida(Saitama International Medical Center), Amy Hutchinson(National Institutes of Health), Xuelian Li(Wuhan Union Hospital), Yang Yang(University of Maryland, Baltimore), Jie Liu(Shandong Tumor Hospital), Kexin Chen(Harbin University of Science and Technology), Yangwu Ren(China Medical University), Minsun Song(Sookmyung Women's University), Jun Yokota(Fukushima Medical University), Meredith Yeager(Frederick National Laboratory for Cancer Research), Chien‐Jen Chen(Academia Sinica), Hideo Kunitoh(Japanese Red Cross Medical Center), Bao Song(Shandong Tumor Hospital), Joseph F. Fraumeni(National Institutes of Health), Charles C. Chung(National Cancer Institute), Ying-Huang Tsai(Chiayi Chang Gung Memorial Hospital), Kyota Ashikawa, Gee‐Chen Chang(National Yang Ming Chiao Tung University), Hongxia Ma(Wuhan Prevention and Treatment Center for Occupational Diseases)
Cited by 58
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k